Maintenance plasma exchange treatment for muscle specific kinase antibody positive myasthenia gravis patients

Background:Anti‐muscle specific kinase antibody positive myasthenia gravis (MuSK MG) is often characterized by a relatively severe and progressive course, refractoriness to standard myasthenia gravis (MG) medications, and an increased risk of myasthenic crisis. We report here successful management o...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of clinical apheresis 2015-10, Vol.30 (5), p.314-319
Hauptverfasser:	Yamada, Chisa, Teener, James W., Davenport, Robertson D., Cooling, Laura
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Age of Onset Autoantibodies - blood Autoantibodies - immunology Autoantigens - immunology Catheter-Related Infections - etiology Combined Modality Therapy Diplopia - etiology Female Humans Immunocompromised Host Immunosuppressive Agents - therapeutic use Infection - etiology maintenance plasma exchange Male Middle Aged MuSK myasthenia gravis Myasthenia Gravis - complications Myasthenia Gravis - drug therapy Myasthenia Gravis - immunology Myasthenia Gravis - therapy Plasma Exchange Receptor Protein-Tyrosine Kinases - immunology Receptors, Cholinergic - immunology Retrospective Studies Treatment Outcome Vascular Access Devices
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!